TNEUROPHARMA
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease. Its technology helps to target the dysfunctional t-cells which helps in detecting Alzheimer's disease through the use of blood samples, enabling patients to detect and treat the disease at the early stage and to prevent any complications in the future. The company was founded in 2018 and is based in Albuquerque, New Mexico.
TNEUROPHARMA
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2018-01-01
Address:
Albuquerque, New Mexico, United States
Country:
United States
Website Url:
http://www.tneuropharma.com
Status:
Active
Contact:
575.644.1361
Email Addresses:
[email protected]
Total Funding:
25 K USD
Investors List
New Mexico Economic Development Department
New Mexico Economic Development Department investment in Grant - TNeuroPharma
Arrowhead Innovation Fund
Arrowhead Innovation Fund investment in Seed Round - TNeuroPharma
Official Site Inspections
http://www.tneuropharma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "TNeuroPharma"
About T-NeuroDx - T-NeuroDx
At T-NeuroDx, we believe in the power of innovative science. At T-NeuroDx, our mission is to transform Alzheimer’s care by commercializing tests for early detection of the disease. This will expand opportunities for the development …See details»
TNeuroPharma - Crunchbase Company Profile
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease.See details»
Contact - T-NeuroDx
Get In Touch Contact us today to learn more about our technology and product innovation, and see how you can benefit from working with us. Name First Last Email Your Message* Subscribe to …See details»
T-NeuroPharma | LinkedIn
TNeuroPharma is developing a T-Track Biomarker that identifies Alzheimer’s patients before brain damage has occurred. This will allow for the testing of drugs that prevent Alzheimer’s. The T …See details»
T-Neuro Pharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for T-Neuro Pharma. Use the PitchBook Platform to explore the full profile.See details»
T-NeuroPharma - Products, Competitors, Financials, Employees ...
Nov 7, 2024 About T-NeuroPharma T-Neuro Pharma focuses on developing biomarkers for the detection of Alzheimer's disease in the pharmaceutical sector. The company has created a T …See details»
TNeuroPharma Company Profile | Management and Employees List
Find contact information for TNeuroPharma. Learn about their Business Services, Research & Development market share, competitors, and TNeuroPharma's email format.See details»
TNeuroPharma - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore TNeuroPharma with its drug pipeline, therapeutic area, technology platform, .See details»
Home - T-NeuroDx
Unlocking the Earliest Stage of Alzheimer’s Disease Detection of the initiating factors of Alzheimer’s Disease are critical for early diagnosis, effective disease management and therapeutic discovery. Today, the biomarker we rely on for …See details»
TNeuroPharma Receives Novel Patent - New Mexico Start-Up Factory
Nov 8, 2022 TNeuroPharma is a portfolio company under the New Mexico Start-Up Factory, an organization that is focused on supporting entrepreneurs in the journey of taking innovative …See details»
T-Neuro Pharma Welcomes Renowned Alzheimer’s Researcher Dr.
T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases, announced today the appointment of Dr. Jeffrey Cummings, MD, …See details»
T-Neuro Pharma - LifeScienceHistory.com
TNeuroPharma’s technology and patented biomarker kit, pharmaceutical companies can, for the first time, identify patients with confirmed Alzheimer’s Disease (AD) to study in their clinical trials – two …See details»
Nextsource | Company Profile | TNeuroPharma
Explore the company profile of TNeuroPharma (tneuropharma.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
TNeuroPharma eyes new partnerships as next financing round nears ...
Aug 14, 2023 Click here to see the full list of New Mexico Inno's 2023 Startups to Watch. TNeuroPharma could land some new, big partnerships in the coming months as it prepares to …See details»
TNeuroPharma - Financial Details - Crunchbase
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease.See details»
Technology - T-NeuroDx
T-NeuroDx was created to provide science-based solutions in the continuing quest to find a treatment for one of today’s most critical public health crises: Alzheimer’s disease. Led by a team of some …See details»
Resources - T-Neuro Pharma
May 13, 2019 T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative therapies for neurodegenerative diseases, announced today the appointment of Dr. …See details»
Albuquerque-based TNeuroPharma lands patent for its Alzheimer's ...
Nov 7, 2022 The approval is for a "method patent," said Kristina Trujillo, TNeuroPharma's CEO. It's licensed exclusively to TNeuroPharma for the company's method of detecting T-cells in patients …See details»
TNeuroPharma - CoBee Company Profile & Funding Rounds
TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease. Its technology helps to target the dysfunctional t …See details»
T-Neuro Pharma Announces Publication of Groundbreaking …
Jul 16, 2024 ALBUQUERQUE, New Mexico — T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative diagnostics and therapeutics for neurodegenerative diseases, …See details»